Celsion Stock Price

0.0192 (1.96%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Celsion Corp CLSN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0192 1.96% 1.00 06:01:43
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
1.01 1.04 0.03 - -
Trades Volume Avg Volume 52 Week Range
15 3,185 12,545,259 0.4305 - 6.50
Last Trade Time Type Quantity Stock Price Currency
06:34:10 1 $ 1.04 USD

Celsion Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.42M 37.42M 33.80M $ 500.00k $ - -0.76 -1.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Celsion News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLSN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.241.280.97151.103,135,225-0.24-19.35%
1 Month1.951.95010.97151.394,199,030-0.95-48.72%
3 Months1.5153.480.97152.2915,627,683-0.515-33.99%
6 Months0.583.480.43051.9710,831,3620.4272.41%
1 Year1.176.500.43052.016,593,173-0.17-14.53%
3 Years2.296.500.43052.012,338,768-1.29-56.33%
5 Years21.9824.080.43052.581,909,164-20.98-95.45%

Celsion Description

Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.